Physician profile
Clinton W Sheets
NPI 1518044940
$6,550.28
in general payments reported to CMS, 2019-2025
22 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,048 · 2020: $279 · 2021: $1,223 · 2022: $849 · 2023: $1,186 · 2024: $912 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,150.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $915.31 | 2022-2025 | Argos, Rocklatan, Tryptyr |
| Allergan, INC. | $763.51 | 2019-2022 | |
| Sight Sciences, INC. | $646.06 | 2022-2025 | Sion Surgical Instrument, Omni Surgical System |
| Abbvie INC. | $550.44 | 2023-2025 | Durysta |
| Glaukos Corporation | $431.90 | 2023-2024 | Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Ivantis, INC | $350.05 | 2019-2021 | |
| New World Medical,INC. | $294.88 | 2020-2024 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Aerie Pharmaceuticals, INC. | $271.13 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $246.85 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $246.82 | 2023-2025 | Syfovre |
| Ellexiscience | $216.43 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $214.69 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $210.24 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Horizon Therapeutics Plc | $205.07 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $202.60 | 2019-2025 | Tecnis Iol, Catalys System, Tecnis Iol |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $196.43 | 2024 | Iheezo |
| Sun Pharmaceutical Industries INC. | $150.89 | 2020-2021 | |
| Rxsight INC | $149.42 | 2023 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Kala Pharmaceuticals, INC. | $124.99 | 2021 | |
| Astellas Pharma US INC | $124.78 | 2023 | Izervay |
| Nova Eye, INC. | $20.04 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Sheets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.